{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:18:18Z","timestamp":1787005098025,"version":"build-2736575974"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Immuno-hematological abnormalities are common among HIV infected individuals as well as patients with highly active antiretroviral therapy (HAART). However, the immuno-hematological outcome of Dolutegravir based antiretroviral therapy (ART) usage is not well investigated.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>To assess hematological and immunological parameters among adult HIV patients before and after initiation of Dolutegravir based ART regimen at St. Peter Specialized Hospital, Addis Ababa, Ethiopia.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A cross-sectional study was conducted from May to July 2021 at St. Peter Specialized Hospital among adult HIV patients. A total of 422 HIV patients on Dolutegravir based ART (combination of Dolutegravir\/lamivudine\/tenofovir disoproxil fumarate (DTG\/3TC\/TDF)) for a minimum of 3 months were selected using convenient sampling methods. Socio-demographic as well as clinical data of the participants was obtained using pre-tested structured questionnaires and a review of medical records. Hematological parameters such as CBC was obtained using Beckman coulter automated hematology analyzer and immunological parameters such as CD4 count were determined using BD FACS presto. Statistical analysis of the data was done using SPSS version 21. Paired t-test was used to compare dependent variables before and after initiation of the new HAART and binary logistic regression was used to determine predictors of immuno-hematological abnormalities. P-value &lt;\u20090.05 was considered as statistically significant.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>Of 422 adult HIV patients, about 273(64.7%) were females. The mean age of study participants was 42.2 years (\u00b110.4SD). The mean white blood cell (WBC) count, red blood cell (RBC) count, hemoglobin (Hb), platelet distribution width (PDW), CD4 count, as well as lymphocyte percentage, neutrophil percentage, and platelet counts (PLT) were increased significantly(P&lt;0.05) after 3 months of the Dolutegravir based therapy. While, red cell distribution width (RDW) and mean cell hemoglobin (MCH) were decreased (P&lt;0.05) after the treatment. Other hematological parameters such as mean cell volume (MCV), hematocrit (HCT), mean cell hemoglobin concentration (MCHC), mean platelet volume (MPV) and platelet distribution width (PDW) showed no significant change. On the other hand, the most common hematological abnormalities identified after the new HAART were anemia (12.1%); followed by Leucopenia (11.3%), neutropenia (6%), and thrombocytopenia (4%). Anemia was associated with female sex (AOR = 7.8, 95% CI: 1.9\u201332.2, P&lt;0.005) and WHO clinical stage III\/IV (AOR = 16, 95% CI: 10.63\u201366.46, P&lt;0.01).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>There was a significant change in certain immuno-hematological parameters such as WBC count, RBC count, PLT count, Hb, PDW, CD4 count, lymphocyte and neutrophil percentage after initiation of the Dolutegravir based therapy. Anemia was the most common hematological abnormality. Further studies are required to fully comprehend the outcome of the new treatment regimen on immuno-hematological parameters.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0310239","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T17:43:58Z","timestamp":1730396638000},"page":"e0310239","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Immuno-hematological parameters among adult HIV patients before and after initiation of Dolutegravir based antiretroviral therapy, Addis Ababa, Ethiopia"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2097-6003","authenticated-orcid":true,"given":"Ayantu","family":"Gudina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1903-9749","authenticated-orcid":true,"given":"Moges","family":"Wordofa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fekadu","family":"Urgessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"key":"pone.0310239.ref001","first-page":"1","volume-title":"Who | Hiv\/Aids","year":"2020"},{"issue":"June","key":"pone.0310239.ref002","first-page":"1","article-title":"Global HIV and AIDS statistics 2020 Fact sheet.","volume":"1","author":"UNAIDS","year":"2020","journal-title":"Glob HIV AIDs ststistics, World AIDS day 2020 Fact Sheet."},{"key":"pone.0310239.ref003","unstructured":"https:\/\/www.un.org\/sexualviolenceinconflict\/wpcontent\/uploads\/2020\/07\/report\/global-aids-update-seizing-the-moment-tackling-entrenched-inequalities-to-end-epidemics\/2020_global-aids-report_en.pdf"},{"issue":"5","key":"pone.0310239.ref004","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/1011-4564.167735","article-title":"A study of the hematological profile of human immunodeficiency virus positive patients in coastal South Indian Region.","volume":"35","author":"D Saha","year":"2015","journal-title":"J Med Sci"},{"issue":"1","key":"pone.0310239.ref005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12878-018-0102-7","article-title":"Prevalence of cytopenias in both HAART and HAART na\u00efve HIV infected adult patients in Ethiopia: A cross sectional study.","volume":"18","author":"TE Fekene","year":"2018","journal-title":"BMC Hematol"},{"key":"pone.0310239.ref006","doi-asserted-by":"crossref","DOI":"10.2147\/JBM.S157148","article-title":"Hematological abnormalities in HIV-antiretroviral therapy na\u00efve clients as seen at an immune suppression syndrome clinic at Mbarara regional referral hospital, southwestern Uganda.","volume":"9","author":"C Katemba","year":"2018","journal-title":"J Blood Med"},{"key":"pone.0310239.ref007","author":"T Friel","year":"2017","journal-title":"Hematologic manifestations of HIV infection: Anemia\u2014UpToDate"},{"key":"pone.0310239.ref008","article-title":"Changes in the haematological parameters of HIV-1 infected children at 6 and 12 months of antiretroviral therapy in a large clinic cohort, North-Central Nigeria.","author":"AO Ebonyi","year":"2017","journal-title":"BMC Hematol."},{"issue":"11","key":"pone.0310239.ref009","first-page":"1","article-title":"Hematological Abnormalities in Early and Advanced HIV Infection Patients.","volume":"3","author":"MB Kumar","year":"2016","journal-title":"Int J Sci Study."},{"issue":"5","key":"pone.0310239.ref010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/bjh.13783","article-title":"Haematological manifestations of human immune deficiency virus infection","volume":"171","author":"P Vishnu","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"pone.0310239.ref011","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/1471-2334-14-496","article-title":"Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda.","volume":"14","author":"R Kyeyune","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0310239.ref012","first-page":"1","article-title":"Prevalence of anaemia before and after the initiation of antiretroviral therapy at ART centre of Hawassa University Referral Hospital, Hawassa, South Ethiopia.","volume":"3","author":"D Daka","year":"2013","journal-title":"Sch J Med"},{"issue":"4","key":"pone.0310239.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm10040877","article-title":"Thrombocytopenia in virus infections.","volume":"10","author":"M Raadsen","year":"2021","journal-title":"J Clin Med"},{"issue":"6","key":"pone.0310239.ref014","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/08830185.2014.893301","article-title":"Neutropenia during HIV infection: Adverse consequences and remedies.","volume":"33","author":"X Shi","year":"2014","journal-title":"Int Rev Immunol"},{"issue":"4","key":"pone.0310239.ref015","first-page":"756","article-title":"Hematologic derangements in HIV\/AIDS patients and their relationship with the CD4 counts: a cross-sectional study.","volume":"13","author":"S Bhardwaj","year":"2020","journal-title":"BMC Hematol."},{"issue":"3","key":"pone.0310239.ref016","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.thromres.2012.12.007","article-title":"Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people","volume":"131","author":"J Vecchiet","year":"2013","journal-title":"Thromb Res"},{"issue":"1","key":"pone.0310239.ref017","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12878-015-0024-6","article-title":"Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, Ethiopia.","volume":"15","author":"M Assefa","year":"2015","journal-title":"BMC Hematol"},{"issue":"11","key":"pone.0310239.ref018","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s40262-013-0093-2","article-title":"Clinical pharmacokinetic, pharmacodynamic and drug-interaction profile of the integrase inhibitor dolutegravir.","volume":"52","author":"ML Cottrell","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"pone.0310239.ref019","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1128\/AAC.05739-11","article-title":"Effect of food on the pharmacokinetics of the integrase inhibitor dolutegravir","volume":"56","author":"I Song","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"16","key":"pone.0310239.ref020","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2169\/internalmedicine.8377-16","article-title":"Severe Thrombocytopenia During Dolutegravir-containing Antiretroviral Therapy","volume":"56","author":"K Nakaharai","year":"2017","journal-title":"Intern Med"},{"issue":"24","key":"pone.0310239.ref021","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.3390\/molecules27249057","article-title":"Pro-Inflammatory Interactions of Dolutegravir with Human Neutrophils in an In Vitro Study.","volume":"27","author":"AJ Theron","year":"2022","journal-title":"Molecules"},{"key":"pone.0310239.ref022","unstructured":"St.Peter Specialized Hospital HMIS."},{"key":"pone.0310239.ref023","author":"WHO","year":"2016","journal-title":"Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity"},{"key":"pone.0310239.ref024","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/JBM.S306369","article-title":"Prevalence of leucopenia and associated factors before and after initiation of ART among HIV-infected patients, north east ethiopia: Cross-sectional study","volume":"12","author":"F Talargia","year":"2021","journal-title":"J Blood Med"},{"key":"pone.0310239.ref025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-0041-1730257","article-title":"Hematological Profile of HIV-Infected Patients on First-Line Highly Active Antiretroviral Therapy and Its Correlation With CD4 Count.","volume":"7","author":"JJ Princy","year":"2021","journal-title":"International Journal of Recent Surgical and Medical Sciences"},{"key":"pone.0310239.ref026","first-page":"477","article-title":"Hematological abnormalities of adult hiv-infected patients before and after initiation of highly active antiretroviral treatment at debre tabor comprehensive specialized hospital, northcentral ethiopia: A cross-sectional study.","volume":"13","author":"S Damtie","year":"2021"},{"issue":"May","key":"pone.0310239.ref027","first-page":"60","article-title":"A Study of Hematological Profile in HIV \/ AIDS","volume":"3","author":"A Wanjari","year":"2013","journal-title":"Aids"},{"issue":"8","key":"pone.0310239.ref028","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00002030-199905280-00003","article-title":"Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients","volume":"13","author":"CM Mastroianni","year":"1999","journal-title":"AIDS"},{"key":"pone.0310239.ref029","author":"S. Acharya","year":"2015","journal-title":"A Study of Hematological Profile in HIV \/ AIDS International Journal of Health Sciences and Research A Study of Hematological Profile in HIV \/ AIDS"},{"issue":"1","key":"pone.0310239.ref030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2052-1839-14-8","article-title":"Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment na\u00efve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: A com.","volume":"14","author":"B Enawgaw","year":"2014","journal-title":"BMC Hematol."},{"key":"pone.0310239.ref031","article-title":"Impact of vitamin supplements on HAART related hematological abnormalities in HIV-infected patients.","author":"E Rezaei","year":"2016","journal-title":"Med J Islam Repub Iran."},{"key":"pone.0310239.ref032","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5210963","article-title":"Impact of HIV infection and zidovudine therapy on RBC parameters and urine methylmalonic acid levels.","volume":"2016","author":"A Adediran","year":"2016","journal-title":"Interdiscip Perspect Infect Dis."},{"key":"pone.0310239.ref033","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5045\/kjh.2011.46.4.253","article-title":"Hematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia.","volume":"46","author":"Y-A Choi","year":"2011","journal-title":"Korean J Hematol"},{"issue":"2","key":"pone.0310239.ref034","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5582\/bst.2015.01024","article-title":"A cross-sectional study of leukopenia and thrombocytopenia among Chinese adults with newly diagnosed HIV\/AIDS","volume":"9","author":"Y Shen","year":"2015","journal-title":"Biosci Trends"},{"issue":"3","key":"pone.0310239.ref035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ajh.10063","article-title":"Management of a patient with HIV infection-induced anemia and thrombocytopenia who presented with thrombotic thrombocytopenic purpura","volume":"69","author":"AC Gruszecki","year":"2002","journal-title":"Am J Hematol"},{"issue":"1\u20132","key":"pone.0310239.ref036","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.ddmec.2011.10.001","article-title":"HIV and SIV Associated Thrombocytopenia: An Expanding Role for Platelets in the Pathogenesis of HIV.","volume":"8","author":"KA Metcalf Pate","year":"2011","journal-title":"Drug Discov Today Dis Mech."},{"issue":"12","key":"pone.0310239.ref037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2010.08.002","article-title":"Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas","volume":"14","author":"C Firnhaber","year":"2010","journal-title":"Int J Infect Dis"},{"key":"pone.0310239.ref038","first-page":"4809","author":"B Li","year":"2021","journal-title":"Manifestations and Related Risk Factors of Thrombocyte Abnormalities in HIV-Positive Patients Before and After the Initiation of ART"},{"key":"pone.0310239.ref039","article-title":"Prognostic importance of anaemia in HIV-1 infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies in industrialized countries HHS Public Access.","volume":"13","author":"RJ Harris","year":"2008","journal-title":"Antivir Ther"},{"issue":"2","key":"pone.0310239.ref040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/IBRR\/2015\/20197","article-title":"Anti-retroviral Treatment Related Haematological Disorders among HIV- Infected Children Attending HIV Clinic at Yekatit 12 Hospital, Addis Ababa, Ethiopia.","volume":"4","author":"M Debasu","year":"2015","journal-title":"Int Blood Res Rev"},{"issue":"1","key":"pone.0310239.ref041","article-title":"Prevalence of thrombocytopenia before and after initiation of HAART among HIV infected patients at black lion specialized hospital, Addis Ababa, Ethiopia: A cross sectional study.","volume":"18","author":"GG Woldeamanuel","year":"2018","journal-title":"BMC Hematol."},{"key":"pone.0310239.ref042","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7196\/SAMJ.5595","article-title":"Haematological complications of HIV infection","volume":"102","author":"J. Opie","year":"2012","journal-title":"South African Medical Journal"},{"issue":"4","key":"pone.0310239.ref043","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3126\/ajms.v7i4.14033","article-title":"Hematological abnormalities in HIV infected individuals in correlation to CD4 counts and ART status.","volume":"7","author":"RR Thulasi","year":"2016","journal-title":"Asian J Med Sci"},{"issue":"1","key":"pone.0310239.ref044","doi-asserted-by":"crossref","DOI":"10.23937\/2469-567X\/1510039","article-title":"Prevalence of Haematological and Serum Biochemical Abnormalities in HIV Infected Patients in Ghana, Before and after Antiretroviral Therapy.","volume":"5","author":"A Samuel Kwadwo","year":"2018","journal-title":"Int J Virol AIDS"},{"issue":"3","key":"pone.0310239.ref045","first-page":"3265","article-title":"Effect of HAART on some haematological parameters,correlations between total lymphocyte and CD4 counts of HIV clients attending ssh, ikole-ekiti.","volume":"4","author":"CO Idowu","year":"2015","journal-title":"Int J Biol Med."},{"issue":"3","key":"pone.0310239.ref046","first-page":"256","article-title":"Correlation Between Baseline Cd4(+) T-Lymphocyte Count and Plasma Viral Load in Aids Patients and Their Early Clinical and Immunological Response To Haart: a Preliminary Study.","volume":"26","author":"H Gautam","year":"2008","journal-title":"Indian J Med Microbiol"},{"issue":"95","key":"pone.0310239.ref047","first-page":"7034","volume":"5","author":"S Vemula","year":"2016","journal-title":"BMC Hematol"},{"key":"pone.0310239.ref048","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/JBM.S137067","article-title":"Hematologic abnormalities and associated factors among HIV infected children pre- and postantiretroviral treatment, North West Ethiopia.","volume":"8","author":"T Geletaw","year":"2017","journal-title":"J Blood Med"},{"key":"pone.0310239.ref049","volume-title":"In: Trends in Basic and Therapeutic Options in HIV Infection\u2014Towards a Functional Cure","author":"WMW Mohamad","year":"2015"},{"issue":"1","key":"pone.0310239.ref050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-016-2182-4","article-title":"Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: Multilevel analysis.","volume":"9","author":"LD Gezie","year":"2016","journal-title":"BMC Res Notes."},{"issue":"6","key":"pone.0310239.ref051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020713","article-title":"Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the australian HIV observational database.","volume":"6","author":"R Rajasuriar","year":"2011","journal-title":"PLoS One."},{"key":"pone.0310239.ref052","first-page":"103","article-title":"Immunological response among HIV\/AIDS patients before and after ART therapy at Zewuditu Hospital Addis Ababa, Ethiopia.","volume":"1","author":"Derbe","year":"2013","journal-title":"BMC Hematol"},{"issue":"3","key":"pone.0310239.ref053","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/431484","article-title":"Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells\/\u03bcL in HIV type 1-infected individuals receiving potent antiretroviral therapy","volume":"41","author":"GR Kaufmann","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"pone.0310239.ref054","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1086\/425075","article-title":"Factors Influencing Increases in CD4 Cell Counts of HIV\u2010Positive Persons Receiving Long\u2010Term Highly Active Antiretroviral Therapy","volume":"190","author":"CJ Smith","year":"2004","journal-title":"J Infect Dis"},{"issue":"17","key":"pone.0310239.ref055","first-page":"2","article-title":"Long-term immunologic response to antiretroviral therapy in lowincome countries: Collaborative analysis of prospective studies: The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration of the International epidemiological Databases to.","volume":"22","author":"D Nash","year":"2009","journal-title":"NIH public access."},{"issue":"5","key":"pone.0310239.ref056","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3904\/kjim.2015.30.5.705","article-title":"The CD4 slope can be a predictor of immunologic recovery in advanced HIV patients: A case-control study","volume":"30","author":"KH Kim","year":"2015","journal-title":"Korean J Intern Med"},{"issue":"3","key":"pone.0310239.ref057","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijid.2007.09.008","article-title":"Predictors of CD4+ cell count response and of adverse outcome among HIV-infected patients receiving highly active antiretroviral therapy in a public hospital in Peru.","volume":"12","author":"D L\u00f3pez de Castilla","year":"2008","journal-title":"Int J Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0310239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T17:44:13Z","timestamp":1730396653000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0310239"}},"subtitle":[],"editor":[{"given":"Enoch","family":"Aninagyei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":57,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0310239","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]}}}